CoTherix is a company developing therapeutic options for pulmonary arterial hypertension.
AdvancingCoTherix is newa company developing therapeutic options for pulmonary arterial hypertension.
Advancing new therapeutic options for pulmonary arterial hypertension
CoTherix is a company in the pharmaceutical industry located in South San Francisco, California . Founded on January 1, 2000 , the organization operates in the United States . CoTherix is a publicly traded company, listed on the NASDAQ stock exchange under the symbol CTRX .
The company's headquarters are also in South San Francisco, California . CoTherix is registered as a company and as an organization . The company's IRS number is 43513144 , and its CIK number is 1138812 . CoTherix falls under the SIC code 2836 .
Company
Company
CoTherix is a company developing therapeutic options for pulmonary arterial hypertension.